Navigation Links
New Technique Could Revolutionize Melanoma Diagnosis and Treatment

Melanoma, a form of skin cancer is the most common tumor to be diagnosed. It has a 99% cure rate if detected early, say researchers from University Hospital of Navarra. // Sadly, the incidence melanoma has been increasing steadily over the recent years. It is the number one killer of women aged between 19 and 50 years. In the U.S., the number of new cases has risen from 6000 to 9000 in just 10 years.

Two main factors regarded to play a major role in the incidence of melanoma are genetic predisposition and exposure to UV light. More specifically, those who suffer form blisters and burns could face an increased risk of developing melanoma following exposure.

The survival rate of melanoma is considerably high. The early detection promises effective surgical treatment of the cutaneous tumor. The diagnosis of melanoma has so far been based on skin biopsy results and clinical experience. This condition has however changed now, with development of the so-called dermatoscopic techniques.

It involves application of a suitable substance over the skin that ensures transparency of the cornel layer. Enhanced visualization of a specific area of the skin can be facilitated through use of different devices. It can be used to differentiate malignant condition from non-malignant conditions, thereby eliminating the need for surgery.

Two widely used techniques in this regard are reflectance confocal microscopy and multiespectral digital dermatoscopy. The former is based on analysis of specific areas of the skin lesion (badly defined or irregular edges). The latter involves photography of the pigmented skin lesion. The images are then processed to facilitate an accurate diagnosis. The patient can then be given the best possible treatment.

The technique is expected to be approved for commercial use in health centers by the FDA (Food and Drug Administration of the USA) in a year. If approved, it could revolutionize the diagnosis and treatm
'"/>




Page: 1 2

Related medicine news :

1. New Laser Techniques cure degeneration of the eye
2. New Technique to Study Infants Brain.
3. New Technique For Benign Breast Tumors
4. Preventing Strokes Using Less Invasive Techniques
5. New Technique To Detect Activity Of Drugs In The Body
6. New Technique To Test Stem Cells That Heal The Heart
7. A New Technique For Prediction Of Adult Height
8. Novel Technique For Targeting Small-Cell Lung Cancer
9. Novel Technique For Management Of Inverted Papilloma Of Frontal Sinus
10. New Cardiac Angiography Technique For Improved Imaging Of Coronary Veins
11. New Technique Enables Better Nursing Of Robin Sequence Infants
Post Your Comments:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...bstetrical anesthesia, whether provided by Certifi...esiologists, is extremely safe//. There is no diff...RNAs compared with those that use only anesthesiol...e study, titled "Anesthesia Staffing and Anestheti...
... new method in ultrasound known as "eSie Touch Ela...Solutions at the ECR 2007 (European Congress of Ra...t this new method, which is an adjunct to regular ...nically relevant differentiation of benign and mal...
...ew research from the University of North Carolina ...wo proteins that may help protect against skin can...line edition of the journal Molecular and Cellular..., named Timeless and Tipin, form a complex that re...
...hubaneswar: Scientists in Orissa have developed a ...others and is bacteria resistant.// A team of scie...ect three years ago to develop a variety of fish t...cterial disease affecting hatcheries in India, Pra...
Other Medicine News:Health News:Obstetrical Anesthesia Equally Safe When Provided by CRNAs or Anesthesiologists 2Health News:eSie Touch Elasticity Imaging, and a Promise of Avoiding Breast Biopsies 2Health News:Researchers Discover Proteins That Protect Against Skin Cancer 2Health News:Scientists Develop Bacteria-resistant Fish 2
(Date:8/17/2008)...Aug. 17 /Xinhua-- Pharmaxis... first pivotal Phase 3,clinical trial of Bronchito...ed enrolment., The first efficacy data from the t...half of 2009. The trial commenced its dosing phase...rget of 250 subjects in June,2008 and closed today...
(Date:8/14/2008)...g. 14 /- Pharmasset, Inc.,(...ompany committed to,discovering, developing and co...s, reported unaudited financial results for the th... reported a net loss attributable to,common stockh....69 for the,quarter ended June 30, 2008, as compar...
(Date:8/14/2008)...pment to begin in late 2008 or in early 2009 -, S...-- Nuvelo, Inc.,(Nasdaq: NUVO ) today announced p... trial of NU172, demonstrating that the direct thr...ticoagulation with a rapid,return toward baseline ...rofile., "NU172 has the potential to address many...
(Date:8/13/2008)...hid Pharma partners with Diakron, MORRIS PLAINS, ...als,Inc. announced today the signing of an exclus...oral anticoagulant drug candidate discovered and,d...& Co. Inc. Under the,terms of the agreement, Diakr...proved, market and distribute the compound worldwi...
Breaking Medicine Technology:Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc. 2America On the Move and More Than 1 500 YMCAs Kick Off Steptember 2007 451 1America On the Move and More Than 1 500 YMCAs Kick Off Steptember 2007 451 2America On the Move and More Than 1 500 YMCAs Kick Off Steptember 2007 451 3America On the Move and More Than 1 500 YMCAs Kick Off Steptember 2007 451 4WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday September 6 2007 337 1WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday September 6 2007 337 2WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday September 6 2007 337 3Nanotechnology 3A Whats that 3F 244 1Nanotechnology 3A Whats that 3F 244 2The aye ayes have it 3A The preservation of color vision in a creature of the night 445 1The aye ayes have it 3A The preservation of color vision in a creature of the night 445 2The aye ayes have it 3A The preservation of color vision in a creature of the night 445 3
...SS WIRE)--Jun 25, 2007 - Gilead,Sciences, Inc. (Na... III clinical trial evaluating the company,s once-...l fumarate or tenofovir,DF) 300 mg as a potential ...ction, met its primary efficacy endpoint. The data... once-daily antiviral,drug Hepsera(R) (adefovir di...
... WIRE)--Jun 25, 2007 - Affymax, Inc.,(Nasdaq:AFFY)...trial results for Hematide(TM) were presented at t...held in Barcelona, Spain by Iain C.,Macdougall, M....ndon. Dr. Macdougall,s poster included data in pre...ive, non-dialysis patients which,demonstrated that...
Other Medicine Technology:Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6Affymax Reports Phase 2 Clinical Dose Ranging Results of,Once-Per-Month Hematide for the Treatment of Anemia 2Affymax Reports Phase 2 Clinical Dose Ranging Results of,Once-Per-Month Hematide for the Treatment of Anemia 3
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: